B

Bioqube Ventures

11 employees

Bioqube Ventures is a specialist life sciences venture capital investor investing in European biotechnology companies

Investor insights

Sectors invested in

Biotechnology8
Therapeutics4
Life Science4
Health Care4
phospatase biology2
oncology2
drug discovery2
Immunomodulation1
Immunotherapy1
Targeted Oncology1
Biopharma1
Drug Discovery1
Santé1
monoclonal antibody1
Healthcare1
vasculatis1
ANCA1

Funding rounds participated in

$1.5M sweet spot round size

Most of their 8 investments are in rounds between $9.3M and $24M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Health Care
Biopharma
Venture Capital

Date founded

2015

Investments made

A

Anavo Therapeutics BV raised $9.3M on May 2, 2023

Investors: Inkef, M Ventures and Bioqube Ventures

B

Bicara Therapeutics raised $108M on March 6, 2023

Investors: Omega Funds, RA Capital Management, L.P., Red Tree Venture Capital, The Invus Group, Premji Invest, F-Prime Capital Partners and Bioqube Ventures

E

Enhanc3D Genomics Ltd raised $11M on October 20, 2022

Investors: Parkwalk Advisors and Bioqube Ventures

T

Tridek-One raised $16M on September 15, 2022

Investors: Pureos Bioventures, Advent Life Sciences, AdBio partners and Bioqube Ventures

E

Egle Therapeutics raised $47M on October 22, 2021

Investors: FundPlus, Takeda UK Limited, EQT Life Sciences and Bioqube Ventures

A

Anavo Therapeutics BV raised $24M on April 22, 2021

Investors: Inkef, M Ventures and Bioqube Ventures

P

Primmune Therapeutics raised $4M on January 12, 2021

Investors: Bioqube Ventures

E

Enhanc3D Genomics Ltd raised undisclosed on January 1, 2021

Investors: Start Codon and Bioqube Ventures

FAQ